How to Monitor Patients with Chronic Myelogenous Leukemia

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.1, Iss.4, 2003-11, pp. : 513-517

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Myelogenous Leukemia Guidelines

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 5, 2007-05 ,pp. : 474-474

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

New Agents in Chronic Myelogenous Leukemia

By Cortes Jorge Giles Francis

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 4, 2003-11 ,pp. : 501-512

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

A case-control study of the effects of hydroxyurea on circulating cortisol levels in patients with acute myelogenous leukemia and chronic myeloproliferative disorders

By Navarra P. Aloe-Spiriti M.A. Boccarini F. Montefusco E. Latagliata R. Preziosi P. Petti M.C.

Pharmacological Research, Vol. 42, Iss. 4, 2000-10 ,pp. : 389-392

Academic Press

Access to resources Recommend Favorite

New Agents in the Treatment of Chronic Myelogenous Leukemia

By Pinilla-Ibarz Javier Quintás-Cardama Alfonso

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 9, 2009-10 ,pp. : 1028-1037

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Chronic Myelogenous Leukemia Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 6, 2005-11 ,pp. : 732-732

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite